Neurofibromatosis 1 (NF1) is an autosomal dominant disorder with a complex
variety of clinical symptoms. Genetic alteration of the NF1 gene on 17q11.2
is the cause of this disease. Neurofibromas of the peripheral nervous syst
em are one main manifestation. A variant of neurofibroma is the plexiform n
eurofibroma which can be found in about 30% of NF1-patients, often causing
severe clinical symptoms. In this study, we examined 14 such tumors from 10
NF1-patients for allele loss of the NF1 gene (LOH: loss of heterozygosity)
using four intragenic polymorphic markers. Loss of heterozygosity was foun
d in eight rumors from five patients, and suspected in one additional tumor
from another patient. This finding suggests that loss of the second allele
, and thus inactivation of both alleles of the NF1 gene, is associated with
the development of plexiform neurofibromas. The 14 plexiform neufibromas w
ere also examined for mutation in the TP53 gene by screening exons 5 throug
h 8 using temperature gradient gel electrophoresis. No mutation was found i
n any of the tumors. (C) Elsevier Science Inc., 1999. All rights reserved.